Form4insider filings, from the source

Company · CIK 0001211583 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq

FENNEC PHARMACEUTICALS INC. · FENC

Insider activity reported against this company. All insider holders · On EDGAR ↗

1M3M6M1Y2YAll datashares as filed — not split-adjusted
Open-market buys & salesbuys $0 · 0sales $1.5M · 6net −$1.5M
$10k$10k$100k$100k$1M$1MbuyssalesSep 2025Nov 2025Jan 2026Mar 2026May 2026Jul 2026Sep 2026

Reported at this company — common stock

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Sep 15, 2026 SForm 4 →Sep 16, 4:05 pm EDTMarco Maria BrugheraDirector15,545$10.29$159,9580−100%10b5-1
Sep 15, 2026 MForm 4 →Sep 16, 4:05 pm EDTMarco Maria BrugheraDirector15,545$2.11$32,80015,545—10b5-1
Sep 1, 2026 SForm 4 →Sep 1, 4:05 pm EDTRosty RaykovOther10,000$12.11$121,100124,411−7.44%10b5-1
Aug 31, 2026 AForm 4 →Sep 1, 4:05 pm EDTRosty RaykovOther2,778——134,411—10b5-1
Aug 31, 2026 SForm 4 →Aug 31, 8:15 pm EDTPierre Sargis SayadChief Medical Officer12,000$12.18$146,1609,519−55.8%
Aug 31, 2026 AForm 4 →Aug 31, 8:15 pm EDTPierre Sargis SayadChief Medical Officer168——21,519—
Aug 31, 2026 AForm 4 →Aug 31, 8:13 pm EDTTerry L EvansChief Commercial Officer168——21,519—
Aug 31, 2026 AForm 4 →Aug 31, 8:12 pm EDTChristiana Marie CioffiChief Strategy Officer156——24,644—
Aug 31, 2026 AForm 4 →Aug 31, 8:10 pm EDTJeffrey S. HackmanChief Executive Officer, Director1,159——66,302—
Aug 31, 2026 AForm 4 →Aug 31, 8:09 pm EDTRobert AndradeCHIEF FINANCIAL OFFICER1,703——241,306—
Aug 28, 2026 MForm 4 →Aug 28, 5:42 pm EDTRobert AndradeCHIEF FINANCIAL OFFICER21,928$5.10$111,833239,603—10b5-1
Aug 27, 2026 SForm 4 →Aug 28, 5:42 pm EDTRobert AndradeCHIEF FINANCIAL OFFICER75,000$11.78$883,500217,675−25.6%10b5-1
Aug 3, 2026 SForm 4 →Aug 4, 4:05 pm EDTRosty RaykovOther10,000$9.58$95,800131,633−7.06%10b5-1
Jul 31, 2026 AForm 4 →Aug 3, 4:05 pm EDTPierre Sargis SayadChief Medical Officer168——21,351—
Jul 31, 2026 AForm 4 →Aug 3, 4:05 pm EDTTerry L EvansChief Commercial Officer168——21,351—
Jul 31, 2026 AForm 4 →Aug 3, 4:05 pm EDTChristiana Marie CioffiChief Strategy Officer156——24,488—
Jul 31, 2026 AForm 4 →Aug 3, 4:05 pm EDTJeffrey S. HackmanChief Executive Officer, Director1,159——65,143—
Jul 31, 2026 AForm 4 →Aug 3, 4:05 pm EDTRosty RaykovOther2,778——141,633—
Jul 31, 2026 AForm 4 →Aug 3, 4:05 pm EDTRobert AndradeCHIEF FINANCIAL OFFICER1,703——292,675—
Jul 1, 2026 SForm 4 →Jul 2, 4:05 pm EDTRosty RaykovOther9,599$10.41$99,926138,855−6.47%10b5-1
Jul 1, 2026 AMForm 4 →Jul 2, 4:05 pm EDTRosty RaykovOther18,375$2.45$38,213148,454—10b5-1
Jun 30, 2026 AForm 4 →Jul 1, 4:38 pm EDTTerry L EvansChief Commercial Officer168——21,183—
Jun 30, 2026 AForm 4 →Jul 1, 4:37 pm EDTPierre Sargis SayadChief Medical Officer168——21,183—
Jun 30, 2026 AForm 4 →Jul 1, 4:36 pm EDTJeffrey S. HackmanChief Executive Officer, Director1,159——63,984—
Jun 30, 2026 AForm 4 →Jul 1, 4:35 pm EDTRobert AndradeCHIEF FINANCIAL OFFICER1,703——290,972—
Jun 30, 2026 AForm 4 →Jul 1, 4:34 pm EDTChristiana Marie CioffiChief Strategy Officer156——24,332—

Reported at this company — derivatives (options, RSUs, warrants)

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Sep 15, 2026 MForm 4 →Sep 16, 4:05 pm EDTMarco Maria BrugheraDirector15,545——220,000—10b5-1
Aug 28, 2026 MForm 4 →Aug 28, 5:42 pm EDTRobert AndradeCHIEF FINANCIAL OFFICER21,928——779,330—10b5-1
Jul 1, 2026 MForm 4 →Jul 2, 4:05 pm EDTRosty RaykovOther15,597$2.45$38,2131,525,000—10b5-1
Jun 10, 2026 AForm 4 →Jun 10, 5:50 pm EDTMarco Maria BrugheraDirector20,000$8.70$174,000235,545—
Jun 10, 2026 AForm 4 →Jun 10, 5:27 pm EDTJodi A CookDirector20,000$8.70$174,000160,000—
Jun 10, 2026 AForm 4 →Jun 10, 5:26 pm EDTKhalid IslamDirector25,000$8.70$217,500250,000—
Jun 10, 2026 AForm 4 →Jun 10, 5:24 pm EDTChris A RallisDirector20,000$8.70$174,000200,000—